liver

HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)

indie 11 January

3 minutes

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic […]

SeaPRwire

Anonymous liver donor brightens CNY for little Raenelle

aseanpr 18 February

5 minutes

SINGAPORE (THE NEW PAPER) – When their daughter Raenelle was diagnosed with biliary atresia – a rare liver disease – at 1½ months old, Ms Vicky Cheng and Mr Roger […]